Note 9 - Equity-Based Compensation (Details) - Stock Options, SARs and RSUs Activity - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		3 Months Ended
		Sep. 30, 2015		Jun. 30, 2015
Stock Options, SARs and RSUs Activity [Abstract]
Outstanding at - Weighted average exercise price (in Dollars per share)		$ 6.14	[1]	$ 5.97
Outstanding at - Weighted average remaining contractual term	[1],[2]	3 years 175 days
Outstanding - Aggregate value (in Dollars)	[1],[3]	$ 12,971
Exercisable at September 30, 2015 (2)	[4]	2,556
Exercisable at September 30, 2015 (2) (in Dollars per share)	[4]	$ 7.47
Exercisable at September 30, 2015 (2)	[2],[4]	2 years 350 days
Exercisable at September 30, 2015 (2) (in Dollars)	[3],[4]	$ 5,255
RSUs granted		8
Options / SARs / RSUs cancelled/forfeited/expired		(6)
Options / SARs exercised and RSUs vested		(134)
Options / SARs exercised and RSUs vested (in Dollars per share)		$ 0.92
Outstanding - Number of options	[1]	3,880

[1] Due to the ceiling imposed on the SAR grants, the outstanding amount above can be exercised for a maximum of 3,266,336 shares of the Company's common stock as of September 30, 2015. SAR grants made prior to January 1, 2009 are convertible for a maximum number of shares of the Company's common stock equal to 50% of the SARs subject to the grant. SAR grants made on or after January 1, 2009 and before January 1, 2010 are convertible for a maximum number of shares of the Company's common stock equal to 75% of the SARs subject to the grant. SAR grants made on or after January 1, 2010 and before January 1, 2012 are convertible for a maximum number of shares of the Company's common stock equal to 66.67% of the SARs subject to the grant. SAR grants made on or after January 1, 2012 are convertible for a maximum number of shares of the Company's common stock equal to 50% of the SARs subject to the grant.

[2] Calculation of weighted average remaining contractual term does not include the RSUs that were granted, which have indefinite contractual term.

[3] Calculation of aggregate intrinsic value is based on the share price of the Company's common stock on September 30, 2015 ($9.11 per share).

[4] Due to the ceiling imposed on the SAR grants, the exercisable amount above can be exercised for a maximum of 1,996,075 shares of the Company's common stock as of September 30, 2015.